纵横研报
Ticker Detail

688363.SHG

¥36.45+6.08% 华熙生物 Specialty Chemicals
00Reports China 基础材料
Bloomage Biotechnology Corp Ltd
基础材料 · 特种化工

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.

MARKET 市值 17.20B CNY PE 66.1x Fwd 41.3x 52W ¥32.92 – ¥61.85 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -23.1% ROE 3.6% 营业利润率 10.8% 净利润率 6.5%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制